ACITRETIN CAPSULES Retinoid Anti-psoriasis

TEVA

Revision date : 2015-01-23

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

9003-39-8

Name of the chemical

polyvinylpyrrolidone

Concentration

N/A

EC/CAS

232-554-6/9000-70-8

Name of the chemical

gelatin

Concentration

N/A

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

205-126-1/9003-11-6

Name of the chemical

poly(ethylene propylene) glycol

Concentration

134-3-

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

236-675-

General Information

Revision date

2015-01-23

Product name

ACITRETIN CAPSULES Retinoid Anti-psoriasis

Chemical name

all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300

Icons in SDS

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product consists of a two-piece capsule filled with yellow powder in the following colors: light green cap and white body (10 mg), yellow cap and yellow body (17.5 mg), and light green cap and yellow body (25 mg). Health Hazards: This product contains a known human teratogen. In the workplace, exposure to dusts from product via inhalation and skin contact may cause irritation. Eye contact from dusts can cause mechanical irritation. Non-therapeutic ingestion may be harmful. In therapeutic use, the most common adverse effects reported include headache and vertigo. Adverse effects on the eyes, pancreas, liver, kidneys and cardiovascular, skeletal and nervous systems have been reported. Exposure may cause sensitivity to UV light and sun light, resulting in sunburn burn. Reports of depression and other psychological effects have occurred, as well as serious adverse skin reactions and adverse effects on the liver. Exposure during pregnancy will harm to fetus. These effects may be possible as a result of workplace exposure. Refer to Section 11 (Toxicological Information) for additional information on adverse effects. Flammability Hazards: This product is combustible and can ignite if highly heated or if exposed to direct flame. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds including carbon and nitrogen oxides). Reactivity Hazards This product is not reactive.

Environmental hazards

May cause harm to aquatic organisms if accidentally released. All environmental release should be avoided. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.